These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6886626)

  • 21. Spontaneous antilymphoma reaction of preleukaemic AKR mice is a non-T-cell killing.
    Gomard E; Leclerc JC; Levy JP
    Nature; 1974 Aug; 250(5468):671-3. PubMed ID: 4854374
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic control of CTL responses to AKR/Gross virus: effect of inheritance of Akv proviruses.
    Green WR; Rich RF
    Immunogenetics; 1988; 27(5):304-12. PubMed ID: 2833435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of inhibition of tumour cell DNA synthesis by immune cells in Gross virus induced leukemia.
    Finklestein JZ; Byfield J; Tittle K; Imagawa DT
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):287-92. PubMed ID: 5053619
    [No Abstract]   [Full Text] [Related]  

  • 24. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
    Green WR
    J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986
    [No Abstract]   [Full Text] [Related]  

  • 25. Histocompatibility antigens on murine tumors.
    Goodenow RS; Vogel JM; Linsk RL
    Science; 1985 Nov; 230(4727):777-83. PubMed ID: 2997918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of H-2:H-7 congenic mice to study H-2-mediated resistance to Friend leukemia virus.
    Wettstein PJ; Blank KJ
    J Immunol; 1982 Jul; 129(1):358-61. PubMed ID: 7086137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.
    Green WR; Nowinski RC; Henney CS
    J Exp Med; 1979 Jul; 150(1):51-66. PubMed ID: 109575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H-21-linked control of immunological resistance to viral leukemogenesis as a response to preleukemic cells.
    Lonai P; Katz E; Peled A; Haran-Ghera N
    Immunogenetics; 1981 Mar; 12(5-6):423-32. PubMed ID: 6260638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2.
    Sato H; Boyse EA; Aoki T; Iritani C; Old LJ
    J Exp Med; 1973 Sep; 138(3):593-606. PubMed ID: 4727915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ; Howe ML
    J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic resistance to lymphoma-leukemia: role of natural killer cells in the rejection of lymphoma grafts.
    Datta SK; Trentin JJ
    Biomed Pharmacother; 1993; 47(10):451-6. PubMed ID: 8061245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 34. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR
    J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract]   [Full Text] [Related]  

  • 37. Genes of the H-2 complex regulate the antibody response to murine leukemia virus.
    Vlug A; Schoenmakers HJ; Melief CJ
    J Immunol; 1981 Jun; 126(6):2355-60. PubMed ID: 6262410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution.
    Klein G
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2442-6. PubMed ID: 221925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serologic and immunochemical studies of the cell membrane alloantigens of K36, an AKR spontaneous leukemia.
    Schmidt W; Festenstein H; Atfield G
    Transplant Proc; 1980 Mar; 12(1):29-31. PubMed ID: 7368291
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunologic mechanisms in the pathogenesis of virus-induced murine leukemia. III. Target cell specificity of autoreactive thymocytes.
    Proffitt MR; Hirsch MS; Ellis DA; Gheridian B; Black PH
    J Immunol; 1976 Jul; 117(1):11-5. PubMed ID: 180178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.